Charmin Broughton, NP
Family · Parker, CONPI 1144634734
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,638 of the $11,436 with a category attached, or 84.3%. It is spread thinly across 33 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,178, 4.7 times the $898 reported in 2021. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $33.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Boston Scientific$2K
- AbbVie$1K
- Lundbeck LLC$741
- Collegium Pharmaceutical, Inc.$600
- Relievant Medsystems, Inc.$549
- plus $4K from 27 others
What the payments were for
- Travel & lodging$1,79816%
- Food & beverage$9,63884%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 13 | $2,502 |
| Boston Scientific | 30 | $1,867 |
| AbbVie | 67 | $1,348 |
| Lundbeck LLC | 26 | $741 |
| Collegium Pharmaceutical, Inc. | 44 | $600 |
| Relievant Medsystems, Inc. | 5 | $549 |
| Scilex Pharmaceuticals Inc. | 28 | $453 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $430 |
| Pfizer | 23 | $429 |
| Biohaven Pharmaceuticals, Inc. | 8 | $406 |
| Painteq LLC | 4 | $242 |
| Lilly USA, LLC | 12 | $198 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $188 |
| Radius Health, Inc. | 4 | $183 |
| MML US, Inc. | 2 | $177 |
| Averitas Pharma Inc. | 8 | $158 |
| Si-bone, Inc. | 2 | $149 |
| Vertos Medical, Inc. | 1 | $138 |
| Amgen | 5 | $93 |
| Vertex | 5 | $89 |
| IBSA Pharma Inc. | 4 | $81 |
| GRT US Holding, Inc. | 7 | $64 |
| Tonix Medicines, Inc. | 2 | $61 |
| Spinal Simplicity, LLC | 2 | $47 |
| Upsher-smith Laboratories LLC | 3 | $45 |
| Medtronic | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Bioventus LLC | 2 | $31 |
| SPR Therapeutics, Inc | 1 | $24 |
| Merck | 1 | $16 |
| Abbott | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$2,207
- Intracept$2,039
- GENERAL PAIN MANAGEMENT$556
- NURTEC ODT$371
- VYEPTI$250
- QULIPTA$249
- UBRELVY$249
- ReActiv8$164
- PAINTEQ$149
- mild Device Kit$138
- Tymlos$110
- WaveWriter Alpha Prime 16$104
How this compares
$11,436 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 66 | $42,255 |
| OxycontinOxycodone Hcl | 51 | $26,925 |
| BelbucaBuprenorphine Hcl | 33 | $25,126 |
| Buprenorphine | 68 | $17,475 |
| UbrelvyUbrogepant | 17 | $16,112 |
| Oxycodone Hcl | 755 | $15,979 |
| MovantikNaloxegol Oxalate | 36 | $13,529 |
| Aimovig AutoinjectorErenumab-Aooe | 16 | $12,011 |
| Fentanyl | 67 | $10,983 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 298 | $10,816 |
| Lidocaine | 97 | $10,597 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 253 | $7,521 |
| GraliseGabapentin | 11 | $6,425 |
| Morphine Sulfate ErMorphine Sulfate | 185 | $5,710 |
| Gabapentin | 226 | $3,434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $600 | $67,38199 claims |
| AbbVieUbrelvy | $1,348 | $16,11217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.
Other family in Parker
- Diana ByrdParker$19K
- Jette HogenmillerParker$19K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.